GB Pharma

Executive Summary

GB Pharma is an established Italian CRO founded in 1990, offering specialized services in pharmacovigilance, regulatory affairs, and clinical research. Over 25 years, it has evolved from a local contract research organization into a global multicountry provider, leveraging deep expertise in drug safety and regulatory compliance. The company serves pharmaceutical and biotech clients, supporting them through the complex drug development lifecycle. As a private entity, GB Pharma focuses on operational excellence and client retention, positioning itself as a reliable partner in the competitive CRO market.

Upcoming Catalysts (preview)

• TBDExpansion into new geographic markets (e.g., US or Asia)40% success
• TBDStrategic partnership with a major pharmaceutical company50% success
• TBDLaunch of a new service line (e.g., real-world evidence or digital health)30% success